Australian Myriad ruling to face appeal

05-03-2013

Australian Myriad ruling to face appeal

Law firm Maurice Blackburn revealed on Monday that it will appeal against an Australian court decision that backed Myriad Genetics’ ownership of a human gene mutation linked to breast cancer.


Myriad, appeal, gene patent, BRCA1, Maurice Blackburn

WIPR